这一类新型药物被称为分子靶向治疗药物(molecular targeted therapeutic drugs，MTTD)。以伊马替尼和美罗华为代表的MTTD分别在慢性粒细胞性白血病(CML)和非霍杰金氏淋巴瘤(NHL)的...
基于4个网页-相关网页
The research results may provide experimental basis for the prognosis of GCT and the molecular targeted therapeutic drugs development.
本研究结果可以为GCT的预后判断及分子靶向药物的开发提供实验依据。
Also, in nononcologic therapeutic areas understanding the molecular biology of the disease increases; thus, the chances of developing specific targeted drugs increase.
另外，在非肿瘤治疗领域，随着从分子生物学角度更好的理解疾病，对于特定靶点药物的研究有所增加。
Advance in our congnition of the molecular mechanism of cancers has led to targeted molecular therapies that may permit the improvement of therapeutic efficacy and reduce the toxicity of drugs.
这一针对恶性肿瘤的新疗法，可以改善肿瘤患者的治疗效果，同时降低药物毒性。
应用推荐